These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6761368)

  • 1. Captopril--a new treatment for severe congestive heart failure.
    Kendall MJ; Smith SR; Thomson MH
    J Clin Hosp Pharm; 1982 Dec; 7(4):231-44. PubMed ID: 6761368
    [No Abstract]   [Full Text] [Related]  

  • 2. Factors predicting acute and long-term response to captopril therapy in congestive heart failure.
    Levine TB; Cohn JN
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):169S-174S. PubMed ID: 6753898
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute and long-term effects of captopril on exercise cardiac performance and exercise capacity in congestive heart failure.
    Kramer B; Topic N; Massie B
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):143S-151S. PubMed ID: 6753895
    [No Abstract]   [Full Text] [Related]  

  • 4. [Captopril in the treatment of severe congestive heart failure. Experience with 10 patients].
    Escobar E; Ojeda G; Saavedra M; Thumala A
    Rev Med Chil; 1983 Nov; 111(11):1123-9. PubMed ID: 6379801
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical and haemodynamic responses to captopril and hydralazine in chronic congestive heart failure: the importance of preload reduction.
    Fitzgerald DJ; O'Callaghan WG; O'Malley K; Horgan J; O'Brien E
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):217S-222S. PubMed ID: 6753903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term treatment of congestive heart failure by captopril: hemodynamic, biological and clinical effects.
    Kayanakis JG; Fauvel JM; Giraud P; Bounhoure JP
    Eur Heart J; 1981 Feb; 2(1):75-81. PubMed ID: 7023947
    [No Abstract]   [Full Text] [Related]  

  • 7. Sustained haemodynamic and clinical effects of captopril in long-term treatment of severe chronic congestive heart failure.
    Ricci S; Zaniol P; Teglio V; Baraldi P; Mattioli G
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):209S-215S. PubMed ID: 6291564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Severe side-effects of captopril].
    Arcavi L; Estrov Z; Caspi A; Resnitzky P
    Harefuah; 1985 May; 108(9):439-41. PubMed ID: 3896985
    [No Abstract]   [Full Text] [Related]  

  • 9. Hyperkinetic circulation associated with captopril therapy for congestive heart failure.
    Fouad FM; Salcedo EE; Saragoca M; Bravo EL; Tarazi RC
    N Engl J Med; 1981 Aug; 305(7):405-6. PubMed ID: 7019709
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical, hemodynamic, plethysmographic and biological effects of the oral converting enzyme inhibitor, captopril (SQ 14225), in the short and medium-team treatment of advanced congestive cardiac failure].
    Kayanakis JG; Fauvel JM; Giraud P; Boccalon H; Puel J; Cassagneau B; Bounhoure JP
    Arch Mal Coeur Vaiss; 1981 Nov; 74(11):1325-32. PubMed ID: 6797371
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of congestive heart failure with captopril].
    Zheng DY
    Zhonghua Nei Ke Za Zhi; 1984 Jan; 23(1):5-9, 61. PubMed ID: 6396047
    [No Abstract]   [Full Text] [Related]  

  • 12. Short and long-term effects of treatment with low dose captopril in patients with severe congestive heart failure.
    Dahlström U; Karlberg BE
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):231S-235S. PubMed ID: 6753905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of captopril in circulatory failure].
    Mareev VIu
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(2):109-14. PubMed ID: 6753872
    [No Abstract]   [Full Text] [Related]  

  • 14. Captopril: clinical pharmacology and benefit-to-risk ratio in hypertension and congestive heart failure.
    Vlasses PH; Ferguson RK; Chatterjee K
    Pharmacotherapy; 1982; 2(1):1-17. PubMed ID: 6765388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute and chronic effects of captopril therapy in patients with refractory heart failure.
    Walsh WF; Lee CL
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):153S-159S. PubMed ID: 6753896
    [No Abstract]   [Full Text] [Related]  

  • 16. Beneficial haemodynamic effect of the angiotensin blocking agent captopril in patients with refractory heart failure.
    Lee CL; MacDonald GJ; Walsh WF
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():93-7. PubMed ID: 6291831
    [No Abstract]   [Full Text] [Related]  

  • 17. Beneficial effects of captopril in left ventricular failure in patients with myocardial infarction.
    Bounhoure JP; Kayanakis JG; Fauvel JM; Puel J
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):187S-191S. PubMed ID: 6753900
    [No Abstract]   [Full Text] [Related]  

  • 18. [Captopril in congestive heart failure (author's transl)].
    Liebau G
    Klin Wochenschr; 1982 Feb; 60(3):107-13. PubMed ID: 6210798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term treatment of congestive heart failure with captopril.
    Komajda M; Eugene M; Evans J; Drobinski G; Laurenceau JL; Grosgogeat Y
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):223S-229S. PubMed ID: 6753904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical, haemodynamic and biochemical effects of angiotensin-converting enzyme inhibition in chronic refractory cardiac failure (author's transl)].
    Kayanakis JG; Giraud P; Puel J; Cassagneau B; Sabot G; Fauvel JM; Bounhoure JP
    Nouv Presse Med; 1981 Apr; 10(19):1583-6. PubMed ID: 6269558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.